GO:0140315 iron ion sequestering activity: Mechanism, Genes

Iron is an essential micronutrient for nearly all organisms, but its redox activity also makes it dangerous when unbound, as free iron can catalyze the generation of cytotoxic reactive oxygen species. To manage this duality, cells and organisms have evolved proteins that bind iron ions and prevent them from interacting with other partners or from localizing to compartments where they would be active. This function is captured by the Gene Ontology term GO:0140315, iron ion sequestering activity, a molecular function that describes the binding of an iron ion for the purpose of restricting its availability or activity. The term is distinct from iron transport or storage activities because its defining feature is the prevention of iron interaction with other partners, rather than the movement or long-term storage of the metal. Researchers study iron ion sequestering activity because it sits at the intersection of nutritional immunity, oxidative stress, and cellular metal homeostasis. Host-defense proteins such as calprotectin sequester transition metals including iron to limit microbial growth, a process that is critical for innate immunity. Conversely, pathogens have evolved siderophore-based systems to scavenge iron even when it is sequestered, highlighting an evolutionary arms race. In human physiology, iron sequestration within macrophages contributes to nutriprive antimicrobial mechanisms that restrict intracellular pathogens. At the same time, excessive or misplaced iron sequestration can contribute to disease, as iron-induced oxidative stress is implicated in neurodegeneration, cardiovascular disease, and cancer. Understanding the molecular players and regulatory logic of iron ion sequestering activity therefore has broad relevance for immunology, microbiology, and translational medicine.

According to the Gene Ontology, GO:0140315 iron ion sequestering activity is defined as binding to an iron ion to prevent it from interacting with other partners or to inhibit its localization to the area of the cell or complex where it is active. In other words, this molecular function is not about transporting iron across membranes or storing it for later use; it is about physically occupying iron ions so that they cannot participate in other biochemical reactions or reach their normal sites of action. This definition places the term in the molecular_function aspect of the ontology and distinguishes it from iron ion binding (GO:0005506) and iron ion transport (GO:0006826), which do not necessarily imply sequestration. The QuickGO entry lists no synonyms for this term, so the official name should be used in annotations and searches.

Iron ion sequestering activity is important because it determines whether iron is available to drive essential biochemistry or to cause oxidative damage, and because it is a central weapon in host-pathogen interactions. Host-defense proteins such as calprotectin sequester transition metals to starve invading microbes, a process known as nutritional immunity. Macrophages use nutriprive antimicrobial mechanisms, including iron restriction, to control intracellular pathogens. At the same time, iron-induced oxidative stress is a driver of human disease, so understanding how iron is sequestered and released is critical for therapeutic development. The term also matters for biotechnology and drug discovery, as bacterial siderophore and ferrichelatase systems that overcome sequestration are targets for new antibiotics.

The following genes and proteins are representative of iron ion sequestering activity and related iron-handling functions, based on published literature.

Iron ion sequestering activity is regulated at multiple levels. Systemically, the hormone hepcidin controls iron availability by promoting ferroportin degradation, thereby influencing how much iron is available for sequestration or transport. At the cellular level, iron regulatory proteins (IRPs) sense iron levels and modulate the translation or stability of mRNAs encoding ferritin, transferrin receptor, and other iron-handling proteins. In the immune system, inflammatory cytokines induce the expression of calprotectin and other metal-sequestering proteins, reinforcing nutritional immunity during infection. Macrophages coordinate iron sequestration with other nutriprive antimicrobial mechanisms in response to microbial signals. Lysosomal iron handling is also regulated by autophagy and ferritinophagy, which control the release of iron from ferritin stores. These regulatory layers ensure that iron sequestration is deployed when needed and relaxed when iron is required for essential processes.

Iron sequestration is a frontline defense against microbial pathogens. Host-defense proteins such as calprotectin sequester transition metals including iron, creating a metal-limited environment that inhibits microbial growth. Macrophages use nutriprive antimicrobial mechanisms, including iron restriction, to control intracellular pathogens such as Salmonella and Mycobacteria. Pathogens counter these defenses by producing siderophores and ferrichelatases that extract iron from host proteins. Dysregulation of this balance can lead to increased susceptibility to infection or to inflammatory tissue damage.

When iron is not properly sequestered, it can catalyze the generation of reactive oxygen species, leading to oxidative damage. Iron-induced oxidative stress is implicated in a wide range of human diseases, including neurodegeneration, cardiovascular disease, and cancer. Cytotoxic reactions driven by iron and metalloenzymes further illustrate the pathological consequences of failed sequestration. Lysosomal iron handling is particularly important because lysosomes can become sites of iron-mediated oxidative damage if sequestration is impaired. Therapeutic strategies that modulate iron sequestration are therefore being explored for these conditions.

Cancer cells often reprogram iron metabolism to support proliferation, and alterations in iron sequestration can influence tumor growth and metastasis. In inflammation, cytokines induce metal-sequestering proteins as part of the acute-phase response, which can both limit infection and contribute to anemia of inflammation. Understanding how iron ion sequestering activity is regulated in these contexts may reveal new therapeutic opportunities.

After intracerebral hemorrhage, iron released from hemoglobin can drive secondary brain injury. Modular nanotherapeutics with spatiotemporal precision have been developed for phase-specific treatment of intracerebral hemorrhage, in part by modulating iron handling. This example illustrates how knowledge of iron sequestration can inform the design of targeted therapies for acute neurological injury.

Direct measurement of iron ion sequestering activity can be performed using competition assays with iron-sensitive dyes such as calcein or FerroOrange, or by using ferrozine-based colorimetric assays to quantify free iron. These methods are useful for validating candidate sequestering proteins identified from CRISPR screens. Siderophore-dependent ferrichelatase assays provide a complementary approach for studying how pathogens acquire iron from host proteins.

CRISPR knockout and activation screens can identify genes that regulate iron sequestration and nutritional immunity. For example, genome-wide screens in macrophages under infection pressure can reveal host factors required to restrict microbial growth. Hits from such screens can then be validated with targeted knockout or overexpression models.

Mass spectrometry-based proteomics can identify proteins that bind iron under different conditions, while metallomics approaches quantify total and labile iron pools. These methods help define the composition of iron-sequestering complexes and how they change during infection or oxidative stress.

Fluorescence imaging with iron-responsive probes and tagged sequestering proteins can reveal where iron is sequestered within cells, such as in lysosomes or phagosomes. Live-cell imaging of pathogen-containing vacuoles can show how host sequestration restricts microbial access to iron.

Researchers studying iron ion sequestering activity-related genes often need to determine whether a candidate gene is causally involved in iron restriction, oxidative stress protection, or nutritional immunity. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such studies, from knockout to knock-in and library screening.

GO:0140315 iron ion sequestering activity defines a molecular function that is central to nutritional immunity, oxidative stress protection, and cellular metal homeostasis. Host-defense proteins such as calprotectin and macrophage nutriprive mechanisms illustrate how iron sequestration restricts microbial growth, while pathogen siderophore systems reveal the evolutionary arms race over iron. Dysregulated iron sequestration contributes to human diseases including neurodegeneration and cancer, making this term a valuable focus for both basic and translational research. CRISPR-based models and functional genomics provide powerful tools to dissect the genes and mechanisms underlying iron ion sequestering activity, and EDITGENE offers comprehensive services to support such studies.